Subscribe to RSS
DOI: 10.1055/a-2085-2299
High Prescribing and State-Level Variation in Z-Drug Use Among Medicare Patients
Funding National Institute of Environmental Health Sciences — http://dx.doi.org/10.13039/100000066; T32- ES007060–31A1
Abstract
Background Z-drugs are nonbenzodiazepine hypnotics used for sleep initiation and maintenance; these drugs increase the risk of fall-related injuries in older adults. The American Geriatrics Society’s Beers criteria classifies Z-drugs as high-risk and strongly recommends avoiding prescribing Z-drugs to older adults due to adverse effects. The study objectives were to determine the prevalence of Z-drug prescribing among Medicare Part D patients and identify state or specialty-dependent prescribing differences. This study also aimed to determine prescribing patterns of Z-drugs to Medicare patients.
Methods Z-drug prescription data was extracted from the Centers for Medicare and Medicaid Services State Drug Utilization Data for 2018. For all 50 states, the number of prescriptions per 100 Medicare enrollees and days-supply per prescription was determined. The percentage of total prescriptions prescribed by each specialty and the average number of prescriptions per provider within each specialty was also determined.
Results Zolpidem was the most prescribed Z-drug (95.0%). Prescriptions per 100 enrollees were significantly high in Utah (28.2) and Arkansas (26.7) and significantly low in Hawaii (9.3) relative to the national average (17.5). Family medicine (32.1%), internal medicine (31.4%), and psychiatry (11.7%) made up the largest percentages of total prescriptions. The number of prescriptions per provider was significantly high among psychiatrists.
Discussion Contrary to the Beers criteria, Z-drugs are prescribed to older adults at high rates.
Publication History
Received: 26 January 2023
Accepted: 17 April 2023
Article published online:
07 June 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Patel D, Steinberg J, Patel P.. Insomnia in the elderly: A review. J Clin Sleep Med 2018; 14: 1017-1024
- 2 Sateia MJ.. International classification of sleep disorders-third edition: Highlights and modifications. Chest 2014; 146: 1387-1394
- 3 Foley DJ, Monjan A, Simonsick EM. et al Incidence and remission of insomnia among elderly adults: An epidemiologic study of 6,800 persons over three years. Sleep 1999; 22 Suppl 2 S366-S372
- 4 Stahl SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. Cambridge, England: Cambridge University Press; 2021
- 5 Treves N, Perlman A, Kolenberg Geron L. et al. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis. Age Ageing 2018; 47: 201-208
- 6 Park SM, Ryu J, Lee DR. et al. Zolpidem use and risk of fractures: A systematic review and meta-analysis. Osteoporos Int 2016; 27: 2935-2944
- 7 Nishtala PS, Chyou T.. Zopiclone use and risk of fractures in older people: Population-based study. JAMDA 2017; 368: e1-e8
- 8 2019 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2019; 67: 674-694
- 9 Pazan F, Gercke Y, Weiss C. et al. The U.S.-FORTA (Fit for the Aged) list: Consensus validation of a clinical tool to improve drug therapy in older adults. JAMDA 2020; 21: 439e9-439e13
- 10 Medicare provider utilization and payment data: Part D Prescriber [Internet]. Cms.gov. [cited 2022 Mar 13] https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Part-D-Prescriber
- 11 Centers for Disease Control and Prevention. 2018 BRFSS survey data and documentation. Cdc.gov. 2019 [cited 2022 May 1] https://www.cdc.gov/brfss/annual_data/annual_2018.html
- 12 Hawaii opioid summary. National Institute on Drug Abuse. 2019 [cited 2022 Mar 13] https://nida.nih.gov/sites/default/files/21954-hawaii-opioid-summary.pdf
- 13 Arizpe A, Reveles KR, Aitken SL.. Regional variation in antibiotic prescribing among Medicare part D enrollees, 2013. BMC Infect Dis 2016; 16: 744
- 14 Explore health measures in Hawaii. America’s Health Rankings. [cited 2022 Mar 13] https://www.americashealthrankings.org/explore/annual/state/HI
- 15 Jones RG. Live in Hawaii, and odds are you’ll need fewer prescription meds. NPR. 2017 Aug 31 [cited 2022 Mar 13] https://www.npr.org/sections/health-shots/2017/08/31/547317533/ornstein-it-s-better-in-hawaii
- 16 Abed Faghri NM, Boisvert CM, Faghri S.. Understanding the expanding role of primary care physicians (PCPs) to primary psychiatric care physicians (PPCPs): Enhancing the assessment and treatment of psychiatric conditions. Ment Health Fam Med 2010; 7: 17-25
- 17 McGinty B. Medicare’s mental health coverage: How COVID-19 highlights gaps and opportunities for improvement. Commonwealth Fund. 2020 [cited 2022 Mar 13] https://www.commonwealthfund.org/publications/issue-briefs/2020/jul/medicare-mental-health-coverage-covid-19-gaps-opportunities
- 18 Cosgrove L, Krimsky S.. A comparison of DSM-IV and DSM-5 panel members' financial associations with industry: A pernicious problem persists. PLoS Med 2012; 9: e1001190
- 19 Sirdifield C, Anthierens S, Creupelandt H. et al. General practitioners' experiences and perceptions of benzodiazepine prescribing: Systematic review and meta-synthesis. BMC Fam Pract 2013; 14: 191
- 20 Data Analysis Brief: Medicare-Medicaid dual enrollment 2006 through 2018. CMS Medicare-Medicaid Coordination Office. 2019 [cited 2022 Mar 13] https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-Office/DataStatisticalResources/Downloads/MedicareMedicaidDualEnrollmentEverEnrolledTrendsDataBrief2006-2018.pdf
- 21 NHPCO Facts and Figures. National Hospice and Palliative Care Organization. 2020 [cited 2022 Mar 13] https://www.nhpco.org/hospice-facts-figures/
- 22 Hojlund M, Gudmundsson LS, Anderson JH. et al. Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020. Basic Clin Pharmacol Toxicol 2022; 32: 60-70
- 23 Sateia MJ, Buysse DJ, Krystal AD. et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2017; 13: 307-349